![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_b9327dc7f4c5dc3665d32f1e77f4d888.svg) | Nodinitib-1 | IC50 | 560.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_3ff34f72ab47a556b7b6a1da1fbefa4c.svg) | 1-(4-Chlorophenyl)sulfonyl-2-benzimidazolamine | IC50 | 90.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_9de157c860ef0d9baabacf7383568cf8.svg) | Ethyl 4-[[4-(3,4-dihydro-1H-isoquinolin-2-ylmethyl)benzoyl]amino]benzoate | IC50 | 150.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_b70c67bfcaa0129960951031d937ed9e.svg) | Cyclopropyl-[5-[4-(4-methoxyphenyl)piperazino]sulfonyl-2-methyl-indolin-1-yl]methanone | IC50 | 510.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_d87371a72a52adfe872d6b2372fe4930.svg) | 1-(4-Chlorophenylmethyl)-2-aminobenzimidazole | IC50 | 7700.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_ab85674942cdcaa602fd4c98a3caa59b.svg) | 1-[5-[4-(4-Chlorophenyl)piperazino]sulfonyl-2-methyl-indolin-1-yl]propan-1-one | IC50 | 1010.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_f91987bf9564a9a441e410e266b6a2f8.svg) | Cyclopropyl-[2-methyl-5-[4-(4-nitrophenyl)piperazino]sulfonyl-indolin-1-yl]methanone | IC50 | 260.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_3fc58177b7247c77a50a94ef561c2917.svg) | CID 44182149 | IC50 | 240.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_a8775c69e1259da3e4e5d0fe335ae679.svg) | CID 44229055 | IC50 | 80.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_371bb1952d2f92a35de16892ad2e79f5.svg) | 1-(Toluene-4-sulfonyl)-1H-benzoimidazole | IC50 | 6300.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_1e9a21630eaeb0077a0b1fa220e00a53.svg) | 1-[4-[4-(1-Acetyl-2-methyl-indolin-5-yl)sulfonylpiperazino]phenyl]ethanone | IC50 | 4420.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_9367458ab55b149a32d33b675519f4a8.svg) | 2-Methyl-1-(4-methylphenyl)sulfonylbenzimidazole | IC50 | 20000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_b4e29bca8e2b7b4935951bb5c60acca4.svg) | (2-Aminobenzimidazol-1-yl)-(4-fluorophenyl)methanone | IC50 | 18000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_cd584f19f44b518da8504251b9625c3c.svg) | 4-(3,4-Dihydro-1H-isoquinolin-2-ylmethyl)-N-p-tolyl-benzamide | IC50 | 3440.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_3ef0bd9474efb91f7240e982d3ebb60f.svg) | N-(4-Chloro-phenyl)-4-(3,4-dihydro-1H-isoquinolin-2-ylmethyl)-benzamide | IC50 | 830.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_f1add2f47f9a849b5f388681d7a06903.svg) | 4-(3,4-Dihydro-1H-isoquinolin-2-ylmethyl)-N-(4-ethoxy-phenyl)-benzamide | IC50 | 1130.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_b1ffd8fc15697b2202ee77bf68f87ab2.svg) | 4-(3,4-Dihydro-1H-isoquinolin-2-ylmethyl)-N-(4-fluoro-phenyl)-benzamide | IC50 | 3110.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_976de1465dfe754f5747b7ff31c73414.svg) | 2-Methyl-5-{[4-(4-nitrophenyl)piperazin-1-yl]sulfonyl}-1-propionylindoline | IC50 | 1870.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_24b344aa77ffc7ac7d61b510d9bb4a6f.svg) | CID 20901603 | IC50 | 5600.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_50ad4f81c9d01069a6f526c017acd129.svg) | Cyclopropyl-[2-methyl-5-(4-phenylpiperazino)sulfonyl-indolin-1-yl]methanone | IC50 | 20000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_bdecf83e805e7da24ea3e7562b3cf120.svg) | 1-[4-[4-[1-(Cyclopropanecarbonyl)-2-methyl-indolin-5-yl]sulfonylpiperazino]phenyl]ethanone | IC50 | 10260.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_262875df0a31d088ba6dd8d7f69ae7c6.svg) | 7-[(E)-But-2-enyl]-3-methyl-8-(3-phenylpropylsulfanyl)purine-2,6-dione | IC50 | 1540.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_db84c9ecdc39db995870f04141a82ba6.svg) | 3-Methyl-7-pentyl-8-(2-phenylethylthio)purine-2,6-dione | IC50 | 940.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_aa19463c7aa48e5cd5d7d02f78830270.svg) | 3-Methyl-7-(phenylmethyl)-8-(propan-2-ylthio)purine-2,6-dione | IC50 | 1220.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_e04728638b9ceced27e907c1166f4ed2.svg) | 7-Benzyl-3-methyl-8-nitropurine-2,6-dione | IC50 | 790.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_105a9cbc24bc76a81398c67f605e487b.svg) | 1-(Phenylsulfonyl)-1H-benzimidazol-2-amine | IC50 | 2200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_ccb67030417698d47826d8706b44d680.svg) | 1-((4-Nitrophenyl)sulfonyl)-1H-benzimidazol-2-amine | IC50 | 14000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_6485e18913db89c766e8ad05a915d8c3.svg) | 1-(4-Methoxyphenyl)sulfonyl-2-benzimidazolamine | IC50 | 2700.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_a5031f7da4004b268e7cdf14d1d37fee.svg) | 5,6-Dimethyl-1-(4-methylphenyl)sulfonyl-2-benzimidazolamine | IC50 | 20000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_0fe76e59d1accec28b3d22587a913937.svg) | 1-(2-Aminobenzimidazol-1-yl)-2-phenylethanone | IC50 | 20000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_9572286fdbfcb31d1d527094dcac7564.svg) | 4-(3,4-Dihydroisoquinolin-2(1H)-ylmethyl)-N-(4-methoxyphenyl)benzamide | IC50 | 510.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_f28f335c7901a97e91f7d96d8aede6dd.svg) | 1-Acetyl-5-{[4-(4-methoxyphenyl)piperazin-1-yl]sulfonyl}-2-methylindoline | IC50 | 3630.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_1e6c173f8f8860535a3ba622f0527ce4.svg) | N-[2-[1-[2-(2,3-Dihydro-1H-inden-5-ylamino)-2-oxoethyl]benzimidazol-2-yl]ethyl]-N-methylbenzamide | IC50 | 400.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_c879d32b1cd39157c6eee351dd400238.svg) | (2-Aminobenzimidazol-1-yl)-(2,4-dichlorophenyl)methanone | IC50 | 2800.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_eca8f5f63670674b7c2df5d3416544d1.svg) | N-(4-Bromophenyl)-4-(3,4-dihydro-1H-isoquinolin-2-ylmethyl)benzamide | IC50 | 1030.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_bd46e875bb74c71043e9b1f50f24ca13.svg) | 1-Pentyl-4-phenylmethoxybenzimidazol-2-amine | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_2d5f63f76d712d2ed787bc5f6d87542b.svg) | 4-Benzyl-1-pentylbenzimidazol-2-amine | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_cb12019a6af9514441c6846f33bf045f.svg) | 3-Pentylbenzo[f]benzimidazol-2-amine | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_f0d25957deba50d4ebf4a8cd09f5d3c0.svg) | 1-Pentylbenzo[e]benzimidazol-2-amine | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_9eb1a5d595893591a180e388533c931f.svg) | N-[2-[1-[2-Oxo-2-(3-propan-2-ylanilino)ethyl]benzimidazol-2-yl]ethyl]benzamide | IC50 | 800.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_a7e8f7fb55124336ee72c5b5fe871932.svg) | N-[2-[1-[2-(Naphthalen-2-ylamino)-2-oxoethyl]benzimidazol-2-yl]ethyl]benzamide | IC50 | 1600.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_0afa48a82c56421012616cb664121913.svg) | N-[2-[5-Chloro-1-[2-(2,3-dihydro-1H-inden-5-ylamino)-2-oxoethyl]benzimidazol-2-yl]ethyl]benzamide | IC50 | 1300.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_8a55bc81307297a226a2a1b40faff234.svg) | N-[2-[1-[2-(2,3-Dihydro-1H-inden-5-ylamino)-2-oxoethyl]benzimidazol-2-yl]ethyl]naphthalene-2-carboxamide | IC50 | 3400.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_73ee1d12d38f2d0b847a04950386fc83.svg) | N-[2-[1-[2-(2,3-Dihydro-1H-inden-5-ylamino)-2-oxoethyl]benzimidazol-2-yl]ethyl]-N-methylnaphthalene-2-carboxamide | IC50 | 200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_528e4e235a3f73bc6a19c6c173fac7d5.svg) | N-(1-Pentylbenzimidazol-2-yl)acetamide | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_ec2cab732a0beba23fa54a181f792e6d.svg) | 1-Pentyl-4-phenylbenzimidazol-2-amine | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_ee1e18859e67e27a9f4743e35931a277.svg) | Methyl 3-[(3S)-7-[3-(dimethylamino)phenoxy]-2,5-dioxo-8-[[2-[[4-(trifluoromethyl)phenyl]methoxy]acetyl]amino]-3,4-dihydro-1H-1,4-benzodiazepin-3-yl]propanoate | IC50 | 580.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_0fd3881f46814a4322190b403dea74a8.svg) | Methyl 3-[(3R)-7-[3-(dimethylamino)phenoxy]-8-[[2-[(3-fluorophenyl)methoxy]acetyl]amino]-2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl]propanoate | IC50 | 1370.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_38e186c15f6093acfa9ccbfd256563c2.svg) | Methyl 3-[(3R)-8-[[2-[(4-bromophenyl)methoxy]acetyl]amino]-7-[3-(dimethylamino)phenoxy]-2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl]propanoate | IC50 | 580.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_9b5391ec9bfa8db8990aa04456b78366.svg) | Methyl 3-[(3R)-7-[3-(dimethylamino)phenoxy]-8-[[2-(naphthalen-2-ylmethoxy)acetyl]amino]-2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl]propanoate | IC50 | 1610.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_3fd58e8c120c7c2424e570849c9ba908.svg) | Methyl 3-[(3R)-7-[4-chloro-3-(dimethylamino)phenoxy]-2,5-dioxo-8-[(2-phenylmethoxyacetyl)amino]-3,4-dihydro-1H-1,4-benzodiazepin-3-yl]propanoate | IC50 | 2900.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_a2a08f8d3d350b0d7c8c61667da49b75.svg) | 3-[(3R)-7-[3-(Dimethylamino)phenoxy]-2,5-dioxo-8-[(2-phenylmethoxyacetyl)amino]-3,4-dihydro-1H-1,4-benzodiazepin-3-yl]-N-propylpropanamide | IC50 | 2360.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_93d943a1ad754a206c28dc1c065a663b.svg) | 3-[(3R)-7-[3-(Dimethylamino)phenoxy]-8-[[2-[(4-fluorophenyl)methoxy]acetyl]amino]-2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl]-N-propylpropanamide | IC50 | 2810.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_4404f6a9f1f8e5ceb81584d42f387763.svg) | N,N-Dibutyl-3-[(3R)-7-[3-(dimethylamino)phenoxy]-2,5-dioxo-8-[(2-phenylmethoxyacetyl)amino]-3,4-dihydro-1H-1,4-benzodiazepin-3-yl]propanamide | IC50 | 1300.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_bb8c5e3aec06dc60aaee4c311a6c0053.svg) | N-[(3R)-7-[3-(Dimethylamino)phenoxy]-2,5-dioxo-3-(3-oxo-3-pyrrolidin-1-ylpropyl)-3,4-dihydro-1H-1,4-benzodiazepin-8-yl]-2-phenylmethoxyacetamide | IC50 | 2370.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_bee3d2f68d7f292e08499754be7393a9.svg) | Methyl 3-[(3R)-2,5-dioxo-8-[(2-phenylmethoxyacetyl)amino]-7-[2,4,5-trichloro-3-(dimethylamino)phenoxy]-3,4-dihydro-1H-1,4-benzodiazepin-3-yl]propanoate | IC50 | 1330.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_508834640df13b00be7849f2727e53f4.svg) | Methyl 3-[(3R)-8-[[2-[(3-chlorophenyl)methoxy]acetyl]amino]-7-[3-(dimethylamino)phenoxy]-2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl]propanoate | IC50 | 1290.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_f82afef80554b6cb5a0f8e3800b885ce.svg) | Methyl 3-[(3R)-8-[[2-[(4-cyanophenyl)methoxy]acetyl]amino]-7-[3-(dimethylamino)phenoxy]-2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl]propanoate | IC50 | 3990.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_6635d60d23ddf360998bbab90fb953b2.svg) | N-Butyl-3-[(3R)-7-[3-(dimethylamino)phenoxy]-2,5-dioxo-8-[(2-phenylmethoxyacetyl)amino]-3,4-dihydro-1H-1,4-benzodiazepin-3-yl]propanamide | IC50 | 1290.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_48197dc5f835988c351a90fb82614297.svg) | N-Cyclopropyl-3-[(3R)-7-[3-(dimethylamino)phenoxy]-2,5-dioxo-8-[(2-phenylmethoxyacetyl)amino]-3,4-dihydro-1H-1,4-benzodiazepin-3-yl]propanamide | IC50 | 8620.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_b3b05935cb1190081d78d9728345f665.svg) | Methyl 3-[(3R)-8-[[2-[(4-chlorophenyl)methoxy]acetyl]amino]-2,5-dioxo-7-(3-pyrrolidin-1-ylphenoxy)-3,4-dihydro-1H-1,4-benzodiazepin-3-yl]propanoate | IC50 | 1390.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_9eb9b2c3290ebe06eaea8f7dea06999e.svg) | 2-[(4-Chlorophenyl)methoxy]-N-[(3R)-7-[3-(dimethylamino)phenoxy]-2,5-dioxo-3-(3-oxo-3-piperidin-1-ylpropyl)-3,4-dihydro-1H-1,4-benzodiazepin-8-yl]acetamide | IC50 | 1060.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_dea321adea95f82ec87613416e232c43.svg) | 3-[(3R)-7-[3-(Dimethylamino)phenoxy]-2,5-dioxo-8-[(2-phenylmethoxyacetyl)amino]-3,4-dihydro-1H-1,4-benzodiazepin-3-yl]-N,N-diethylpropanamide | IC50 | 1270.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_a96d7f710338b5e5efa4e525a8622acf.svg) | Methyl 3-[(3R)-7-[3-(dimethylamino)phenoxy]-2,5-dioxo-8-[[2-[[4-(trifluoromethyl)phenyl]methoxy]acetyl]amino]-3,4-dihydro-1H-1,4-benzodiazepin-3-yl]propanoate | IC50 | 940.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_ba4c252f9f25c221e2d7808197df91d5.svg) | N-[(3S)-7-[3-(Dimethylamino)phenoxy]-3-methyl-2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-8-yl]-2-[[4-(trifluoromethyl)phenyl]methoxy]acetamide | IC50 | 1930.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_f2969b7b43fa1549c98e0512e96f661c.svg) | N-[(3R)-7-[3-(Dimethylamino)phenoxy]-2,5-dioxo-3-(3-oxo-3-piperidin-1-ylpropyl)-3,4-dihydro-1H-1,4-benzodiazepin-8-yl]-2-phenylmethoxyacetamide | IC50 | 1110.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_8e88bc0c89de19e01f0c934808bcccc4.svg) | Methyl 3-[(3R)-7-[3-(dimethylamino)phenoxy]-8-[[2-[(4-fluorophenyl)methoxy]acetyl]amino]-2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl]propanoate | IC50 | 2360.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_a5eea41e53bcd8c962c83556d0c82d21.svg) | N-[(3R)-3-[3-(4,4-Difluoropiperidin-1-yl)-3-oxopropyl]-7-[3-(dimethylamino)phenoxy]-2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-8-yl]-2-[[4-(trifluoromethyl)phenyl]methoxy]acetamide | IC50 | 430.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_a9b23cae68230183d290cf3e515742a0.svg) | N-Tert-butyl-3-[(3R)-7-[3-(dimethylamino)phenoxy]-2,5-dioxo-8-[(2-phenylmethoxyacetyl)amino]-3,4-dihydro-1H-1,4-benzodiazepin-3-yl]propanamide | IC50 | 1110.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_51c2e413537ab95ff240f654f1b8c329.svg) | Methyl 3-[(3R)-7-[4-chloro-3-(dimethylamino)phenoxy]-8-[[2-[(4-chlorophenyl)methoxy]acetyl]amino]-2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl]propanoate | IC50 | 1550.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_4cbb54c4f79458788f1e97bcc79fc79a.svg) | Methyl 3-[(3R)-8-[[2-[(4-tert-butylphenyl)methoxy]acetyl]amino]-7-[3-(dimethylamino)phenoxy]-2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl]propanoate | IC50 | 1960.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_9ffa54b99c87a3600eb9998d1681e59b.svg) | Methyl 3-[(3R)-8-[[2-[(3-bromophenyl)methoxy]acetyl]amino]-7-[3-(dimethylamino)phenoxy]-2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl]propanoate | IC50 | 1330.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_419ee5aca2dec56356ca4d497fa437b9.svg) | 3-[(3R)-7-[3-(Dimethylamino)phenoxy]-2,5-dioxo-8-[(2-phenylmethoxyacetyl)amino]-3,4-dihydro-1H-1,4-benzodiazepin-3-yl]-N,N-dimethylpropanamide | IC50 | 4950.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_a02492beab9d577199c7161613f6d91c.svg) | Methyl 3-[(3R)-8-[[2-[(3,4-difluorophenyl)methoxy]acetyl]amino]-7-[3-(dimethylamino)phenoxy]-2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl]propanoate | IC50 | 1160.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_ad8ac9eef4f4cd79100c25da6c86d033.svg) | Methyl 3-[(3R)-8-[[2-[(4-chlorophenyl)methoxy]acetyl]amino]-7-[3-(dimethylamino)phenoxy]-2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl]propanoate | IC50 | 610.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_bc2009b5c9944b2180e946ccfa411ffd.svg) | N-[(3R)-7-[3-(Dimethylamino)phenoxy]-3-[3-(4-fluoropiperidin-1-yl)-3-oxopropyl]-2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-8-yl]-2-[[4-(trifluoromethyl)phenyl]methoxy]acetamide | IC50 | 580.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_c06ca0cdea5c4240fe5a52a564710c13.svg) | 1-[4-[4-(1-Acetylindolin-5-yl)sulfonylpiperazino]phenyl]ethanone | IC50 | 17400.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_620d6a7e65c4f2bd1432b21e65a8e38e.svg) | 1-[5-[4-(4-Acetylphenyl)piperazino]sulfonylindolin-1-yl]propan-1-one | IC50 | 20000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_cfab57c7fea2b246cd7aedfb2c0d10c8.svg) | 1-Acetyl-5-{[4-(4-chlorophenyl)piperazin-1-yl]sulfonyl}-2-methylindoline | IC50 | 2570.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_34dbb829e8e2d7a449019beb482dae59.svg) | 5-{[4-(4-Chlorophenyl)piperazin-1-yl]sulfonyl}-1-propionylindoline | IC50 | 20000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_6d147453d43d6f339899773bef158c3e.svg) | N-(4-Methoxyphenyl)-4-(piperidin-1-ylmethyl)benzamide | IC50 | 20000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_28d458c03da30a32ae361b2316c30cdc.svg) | 1-[2-Methyl-5-(4-phenylpiperazino)sulfonyl-indolin-1-yl]ethanone | IC50 | 11150.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_39d2fba40155dbb2ccf570b8a10ebb0f.svg) | 1-[4-[4-[1-(Cyclopropanecarbonyl)indolin-5-yl]sulfonylpiperazino]phenyl]ethanone | IC50 | 20000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_c4de9942424de2f59ad53a30b528ca60.svg) | 1-[5-[4-(4-Nitrophenyl)piperazino]sulfonylindolin-1-yl]ethanone | IC50 | 20000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_01e629e4c4d84bd4d0a95db2d2a79837.svg) | N-(4-Ethoxyphenyl)-4-(piperidin-1-ylmethyl)benzamide | IC50 | 20000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_5c0aeb0ce185f6ef8368d182fa4d339b.svg) | N-(4-Fluorophenyl)-4-(piperidin-1-ylmethyl)benzamide | IC50 | 20000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_aef40e2a5943da3133ab3511ccddcf7e.svg) | CID 42370913 | IC50 | 20000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_3c8bebeac807eb73c53d25ca63ae5e2c.svg) | CID 44182107 | IC50 | 20000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_4c18a20fb92982c7ce0f044e7c7e8fcf.svg) | CID 44182108 | IC50 | 20000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_6506b1d2aa55652eff8e52e0a7f35ae0.svg) | 1-[2-Methyl-5-[4-(4-nitrophenyl)piperazino]sulfonyl-indolin-1-yl]ethanone | IC50 | 1700.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_e0625b675b9c7279b4922ece0e55fec2.svg) | 1-[5-[4-(4-Acetylphenyl)piperazino]sulfonyl-2-methyl-indolin-1-yl]propan-1-one | IC50 | 2000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_70cb07d22269c928f6725d1bad076567.svg) | 1-[2-Methyl-5-[4-(p-tolyl)piperazino]sulfonyl-indolin-1-yl]ethanone | IC50 | 5760.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_620e82c74ed4d9f2fd45c31110cc6c5e.svg) | Cyclopropyl-[2-methyl-5-[4-(p-tolyl)piperazino]sulfonyl-indolin-1-yl]methanone | IC50 | 20000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_2f82dd447fc17e0991514fd6cd03b5a3.svg) | CID 44182148 | IC50 | 20000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_83184441dd0c0470d39749c8535d9ef9.svg) | CID 44182150 | IC50 | 20000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_d93d6ea7add9f68d23ccdeba0fac4f18.svg) | CID 44229052 | IC50 | 20000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_cf371dca066230c96881b138276499d4.svg) | CID 44229053 | IC50 | 1610.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_97d7f68feab5ee9dd438050e3443ddfa.svg) | CID 44229054 | IC50 | 20000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_60990f59564cbe405240bca678bbe8fa.svg) | CID 44229056 | IC50 | 20000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nucleotide-binding-oligomerization-domain-containing-protein-1_cfae5ca4e63160be50caee57e64da8dc.svg) | Ethyl 4-[[4-[2-(3,4-dihydro-1H-isoquinolin-2-yl)ethyl]benzoyl]amino]benzoate | IC50 | 10600.0 [1] |